Charm Care Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Charm Care is forecast to grow earnings and revenue by 7.8% and 7.6% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 18.8% in 3 years.
Anahtar bilgiler
7.8%
Kazanç büyüme oranı
7.8%
EPS büyüme oranı
Healthcare kazanç büyümesi | 9.0% |
Gelir büyüme oranı | 7.6% |
Gelecekteki özkaynak getirisi | 18.8% |
Analist kapsamı | Low |
Son güncelleme | 02 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
6/30/2027 | 59,300 | 5,400 | N/A | 6,978 | 1 |
6/30/2026 | 55,700 | 5,200 | N/A | 5,502 | 1 |
6/30/2025 | 49,600 | 4,750 | N/A | 4,797 | 1 |
6/30/2024 | 47,829 | 4,276 | 8,806 | 10,534 | N/A |
3/31/2024 | 44,985 | 3,926 | N/A | N/A | N/A |
12/31/2023 | 41,623 | 3,585 | 2,451 | 5,333 | N/A |
9/30/2023 | 40,546 | 3,304 | N/A | N/A | N/A |
6/30/2023 | 37,887 | 3,206 | -1,617 | 496 | N/A |
3/31/2023 | 29,949 | 1,795 | N/A | N/A | N/A |
12/31/2022 | 31,411 | 3,155 | -1,975 | -231 | N/A |
9/30/2022 | 30,437 | 3,051 | N/A | N/A | N/A |
6/30/2022 | 29,071 | 2,951 | 1,336 | 3,945 | N/A |
3/31/2022 | 27,498 | 2,675 | N/A | N/A | N/A |
12/31/2021 | 24,130 | 1,292 | -2,395 | 1,361 | N/A |
9/30/2021 | 23,348 | 1,466 | N/A | N/A | N/A |
6/30/2021 | 22,984 | 1,535 | 124 | 2,558 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 6062's forecast earnings growth (7.8% per year) is above the savings rate (0.3%).
Kazançlar ve Piyasa: 6062's earnings (7.8% per year) are forecast to grow slower than the JP market (8.9% per year).
Yüksek Büyüme Kazançları: 6062's earnings are forecast to grow, but not significantly.
Gelir ve Pazar: 6062's revenue (7.6% per year) is forecast to grow faster than the JP market (4.2% per year).
Yüksek Büyüme Geliri: 6062's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 6062's Return on Equity is forecast to be low in 3 years time (18.8%).